State Health Investment Project: Impact Evaluation Endline Survey, 2017
Nigeria, 2017
Get Microdata
Reference ID
NGA_2017_HRBFIE-EL_v01_M
Producer(s)
Eeshani Kandpal (World Bank)
Created on
Dec 05, 2022
Last modified
Aug 28, 2024
Page views
49738
Downloads
208
- Data files
- cardio_drugs_noid.dta
- Catchment_Area_noid.dta
- decr_services_noid.dta
- diagnostic_kits_noid.dta
- FP_drugs_noid.dta
- general_drugs_noid.dta
-
Health Facility
(HF1)_noid.dta - HF1_Sect08_noid.dta
- HF1_sect10A_noid.dta
- HF1_Sect10B_noid.dta
- incr_services_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
- malaria_drugs_noid.dta
- obstetric_care_noid.dta
- Q1611_positions_noid.dta
- services_noid.dta
- TB_drugs_noid.dta
- vaccines_noid.dta
- anc_patients_noid.dta
- HF3_HCP_Info_noid.dta
- HF4_HCP_Info_noid.dta
- HF4_patients_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
-
Patient DIRECT
OBSERVATION
(HF3_HF4)_noid.dta - HF5_ASSETS_noid.dta
- HF5_LIVESTOCK_noid.dta
- HF5_patients_noid.dta
- HF6_ASSETS_noid.dta
- HF6_LIVESTOCK_noid.dta
- HF6_patients_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
-
Patient EXIT
INTERVIEW
(HF5_HF6)_noid.dta -
Health Care
Provider
Interviews
(HF7)_noid.dta - HF7_Q202_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
- staff_roster_noid.dta
- Durable_Goods_noid.dta
- hhroster_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
-
NSHIP IE
Midline
Household Women
Questionnaire_noid.dta - Q16_13_noid.dta
- S5C_Assets_noid.dta
- S9_Vaccines_noid.dta
- Sec_05B_noid.dta
- Sec_06A_noid.dta
- Sec_06B_noid.dta
- Sec_06C_noid.dta
- Sec_07_noid.dta
Q11.20d. UNIT (Q1120d2)
Data file: cardio_drugs_noid.dta
Overview
Valid:
558
Invalid:
-
Minimum:
-999999999
Maximum:
9
Type:
Discrete
Decimal:
0
Start:
16
End:
25
Width:
10
Range:
-999999999 - 9
Format:
Numeric
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| -999999999 | 1 |
0.2%
|
|
| 1 | UNIT | 0 |
0%
|
| 2 | TAB | 0 |
0%
|
| 3 | DOSE | 0 |
0%
|
| 4 | MG | 498 |
89.2%
|
| 5 | CAPSULE | 0 |
0%
|
| 6 | ML | 22 |
3.9%
|
| 7 | IU | 0 |
0%
|
| 8 | VIALS | 0 |
0%
|
| 9 | OTHER (SPECIFY) | 37 |
6.6%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.